NCT00003960View on ClinicalTrials.gov

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

September 30, 2001

Study Completion Date

September 30, 2001

Conditions
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
DRUG

busulfan

DRUG

cyclophosphamide

DRUG

methylprednisolone

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

Trial Locations (2)

21231

Johns Hopkins Oncology Center, Baltimore

29203

Center for Cancer Treatment and Research, Columbia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00003960 - Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter